Luthringer Remy 13D/13G Filings for Minerva Neurosciences, Inc. (NERV)

Luthringer Remy 13D and 13G filings for Minerva Neurosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-11
09:06 am
Sale
2021-12-31 13G Minerva Neurosciences, Inc.
NERV
Luthringer Remy 132,470
2.500%
-268,565decrease
(-66.97%)
Filing
2021-02-16
06:02 am
Purchase
2020-12-31 13G Minerva Neurosciences, Inc.
NERV
Luthringer Remy 401,035
7.500%
53,023increase
(+15.24%)
Filing